Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.86
-0.19 (-3.14%)
At close: Dec 20, 2024, 4:00 PM
5.80
-0.06 (-1.02%)
After-hours: Dec 20, 2024, 7:58 PM EST
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
66
Market Cap
497.74M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Auna S.A. | 1.17B |
| Talkspace | 181.29M |
| Semler Scientific | 58.94M |
| Cartesian Therapeutics | 47.94M |
| EyePoint Pharmaceuticals | 45.71M |
| Phathom Pharmaceuticals | 26.27M |
| Verve Therapeutics | 24.40M |
| MeiraGTx Holdings | 13.93M |
TERN News
- 17 days ago - Terns's stock soars as analysts cheer leukemia data — and predict more gains - Market Watch
- 18 days ago - Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - Market Watch
- 19 days ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 4 weeks ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 4 weeks ago - Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewsWire
- 5 weeks ago - RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking. - Market Watch
- 3 months ago - Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst - Seeking Alpha
- 3 months ago - Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic - Seeking Alpha